Global Auto Injectors Market is likely to register CAGR of 21.4% through 2032

By 2032, the global auto injectors market size is projected to be worth US$ 23.9 billion, with a remarkable compound annual growth rate (CAGR) of 21.4% from 2022 to 2032. In 2021, the market was valued at US$ 3.1 billion, and it is anticipated to reach approximately US$ 3.5 billion in 2022. The growth of the auto injectors market can be attributed to the increased prevalence of various disorders, including diabetes, anaphylaxis, and multiple sclerosis, among others. Moreover, the surge in self-administration of drugs further drives the demand for auto injectors during the forecast period.

Auto injectors are medical devices that deliver a specific dose of medication. These devices reduce dependency on healthcare professionals to some extent and minimize needle-related injuries and needle phobia, which is a common issue among patients. Additionally, auto injectors offer higher accuracy, user-friendliness, and less pain compared to traditional drug delivery systems. They deliver a painless and complete dosage of the drug, making them preferred over other drug delivery methods. Moreover, the convenience factor is also contributing to the impressive growth rate of the auto injectors market during the projected period.

Request Sample Copy of Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1642

Furthermore, as chronic diseases spread around the world, patients are looking for novel treatments and disease management choices. Because traditional drug delivery methods are time consuming, unpleasant, and painful, many patients are turning to enhanced drug delivery methods such as auto injectors to treat their illnesses and relieve symptoms. As a result, the market for auto injectors is expected to grow rapidly between 2022 and 2032.

“A swell in chronic diseases along with the rising demand for new and efficient drug delivery system is expected to propel the market growth of the auto injectors over the forecast period,” says an FMI analyst.  

Key Takeaways:

• Rising trend of administrating medical products at home is facilitating market expansion.
• Stringent regulatory approvals, premium pricing, and recall of the products may hinder the market growth.
• Increasing regulatory approvals drive the market growth in the US
• Auto injectors market in Canada is likely to register 19.7% CAGR.
• Pre-filled auto injectors will record a 21.6% CAGR over the forecast period.
• By indication, anaphylaxis will maintain market domination over the assessment period.

Talk to Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-1642

Competitive Landscape 

Becton, Dickinson and Company, Sanofi, Pfizer, Inc, Mylan N.V., Novartis AG, Bayer AG, Janssen Global Services, LLC, Antares Pharma, Inc., Amgen Inc, Eli Lilly and Company, Teva Pharmaceutical, Merck KgaA, GlaxoSmithKline plc, Ypsomed, SHL Medical, Gerresheimer AG, Midas Pharma GmbH, Aptar Pharma, Solteam Medical, Stevanato Group, E3D, and West Pharmaceutical Services, Inc., among others are some of the major players in the auto injectors market profiled in the full version of the report.

Leading market players are focusing on releasing new products and approvals. These businesses also engage in mergers, acquisitions, partnerships, collaborations, and price reduction to expand their consumer base

More Insights into Auto Injectors Market Report

According to the latest FMI reports, based on region, the auto injectors market in Canada is expected to present remarkable growth over the assessment period. The market in this country is predicted to register a CAGR of 19.7% during 2022 to 2032. Growing health awareness, high prevalence of chronic diseases, and increasing popularity of auto injectors drive the market growth in this region. Apart from Canada, the US and Germany are also projected to undergo notable growth during this period of observation. While the US market is propelled by the growing cases of diabetes and anaphylaxis, the auto injectors market in Germany is driven by the inclination to minimize the risk of needle-related injuries and a preference for auto injectors.

Based on segmentation, on the basis of product type, the pre-filled auto injector segment is expected to dominate the market. In terms of indication, the anaphylaxis segment will account for the highest CAGR while, on the basis of distribution channel, online pharmacies will witness the highest sales.

Buy Now@ https://www.futuremarketinsights.com/checkout/1642

Key Market Segments Covered in Auto-Injectors Industry Research

By Product:

• Prefilled Auto-Injectors
• Fillable Auto-Injectors

By Indication:

• Anaphylaxis
• Multiple Sclerosis
• Rheumatoid Arthritis
• Others

By Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Drug Stores

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs